| 1 |
34237099 | Gemcitabine-induced Gli-dependent activation of hedgehog pathway resists to the treatment of urothelial carcinoma cells. | 2021 |
1 |
| 2 |
34623580 | Silencing GS Homeobox 2 Alleviates Gemcitabine Resistance in Pancreatic Cancer Cells by Activating SHH/GLI1 Signaling Pathway. | 2021 Oct 8 |
2 |
| 3 |
32721465 | MGMT expression affects the gemcitabine resistance of pancreatic cancer cells. | 2020 Oct 15 |
1 |
| 4 |
30382189 | The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. | 2019 Mar |
4 |
| 5 |
28259943 | Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer. | 2017 Apr |
3 |
| 6 |
27758883 | Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. | 2016 Dec 1 |
1 |
| 7 |
24519751 | Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency. | 2014 Apr |
1 |
| 8 |
23178452 | MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2. | 2013 Feb 28 |
1 |
| 9 |
21630164 | Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines. | 2011 |
2 |